ClinicalTrials.Veeva

Menu

Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy

University of Pennsylvania logo

University of Pennsylvania

Status

Completed

Conditions

Family Planning

Treatments

Other: WHO Decision-Making Tool for Family Planning Clients and Providers

Study type

Interventional

Funder types

Other
NIH

Identifiers

Details and patient eligibility

About

The goal of this pilot study is to assess both implementation outcomes (acceptability, feasibility and adoption) and clinical efficacy (contraceptive method uptake by women wishing to avoid pregnancy) using a Hybrid Type 2 study design of a family planning program being piloted by the Cervical Cancer Prevention Program in Gabarone, Botswana.

Enrollment

248 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Female
  2. English or Setswana speaking
  3. Receiving CCP services at the clinic
  4. 18-45 years of age
  5. Able to give informed consent to study procedures, as determined by research/clinic staff

Exclusion criteria

  1. Pregnant

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

248 participants in 1 patient group

Full group
Other group
Description:
Our goal is to assess the feasibility and acceptability of incorporating family planning (FP) service delivery, using a program validated by the World Health Organization (WHO), into the established Cervical Cancer Prevention (CCP) programs of Botswana.
Treatment:
Other: WHO Decision-Making Tool for Family Planning Clients and Providers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems